Wings of Hope

WPI’s commitment to discovery has already inspired much hope worldwide. Now it is time to put hope into action by offering meaningful patient care to these underserved populations.

Pages

▼

Friday, March 1, 2013

Interview with Vincent Lombardi, Ph.D- Part 2

›

Many patients have written and asked WPI for further information about the recent study titled, Plasmacytoid Dendritic Cells in t...

Friday, February 22, 2013

Interview with Vincent Lombardi, Ph.D. - Part 1

›

Many patients have written and asked WPI for further information about the recent study titled, Plasmacytoid Dendritic Cells in the Duodenu...

4 comments:

Friday, February 1, 2013

My letter to the FDA regarding Ampligen

›

Dear Sir or Madam: As someone who has lived with ME for 25 years this January, I ask you to please approve Ampligen for a subset of severel...

1 comment:

Wednesday, January 30, 2013

ME Lecture by Dr. Kenny De Meirleir at WPI

›

ME/CFS from Infectious Disease to Autoimmune Disorder Dr. Vincent Lombardi, WPI Research Director, introduced Dr. De Meirlei...

Tuesday, January 22, 2013

Ampligen: A successful drug for the most severe ME patients

›

The FDA advisory committee met to discuss Ampligen and its use as a treatment for chronic fatigue syndrome, better known as ME/CFS. Desp...

›

Home

View web version

Powered by Blogger.